BOC Sciences Grandly Promotes: One-Stop CDMO Service Platform for Drug Development 

BOC Sciences Fermentation CDMO Services Prompt a New Era for Pharmaceutical Compound Production

BOC Sciences Contributes to a Large Portion of PseudoUridine Production for mRNA Vaccine R&D

BOC Sciences Commitment at BIO 2022: From Concept to GMP Production

IgGenix Demonstrates Potential for Single-Cell RNA-Sequencing in Tree Nut Allergies

CD ComputaBio Boosts Your Disease Research with Computational Proteomics Service

Innovative Impurity Isolation and Identification Techniques at BOC Sciences to Address Pharmaceutical Impurity Issues

BOC Sciences announced impurity isolation and identification services using traditional and innovative impurity techniques.

NRG Therapeutics Selects Domainex to be its Integrated Drug Discovery Partner for its Biomedical Catalyst Funded Parkinson’s Disease Project

MultiOmic Health and Mesh Bio partner to use AI to develop precision medicines and diagnostics for chronic metabolic disease

MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, and Mesh Bio, a digital health startup transforming chronic disease management through predictive analytics, today announce their partnership to conduct an observational clinical study on patients with chronic metabolic disease and increased risk of complications such as chronic kidney disease. The partnership will provide access to data from patient populations in Asia that have historically been underrepresented in chronic metabolic disease studies.

Introducing Inizio: Ashfield and Huntsworth unite expertise to form powerful strategic partner for health and life sciences companies

Saama Technologies Announces Appointment of New CEO Vivek Sharma

#1 AI clinical analytics platform company Saama Technologies welcomes global life sciences industry expert Vivek Sharma as new CEO

Kyruus Announces Paul Merrild as Company’s First President

Leadership Team Expansion Follows Year of Accelerated Growth

PHASTAR Names Chris Schoonmaker as Chief Operations Officer

PHASTAR Names Chris Schoonmaker as Chief Operations Officer  London, UK and Durham, NC - June 29, 2022 – PHASTAR, a global specialist biometrics contract research organization (CRO) offering industry leading data management, data science, statistical consulting, and clinical trial reporting services, today announces that Chris Schoonmaker has joined the company as Chief Operations Officer. Chris will direct PHASTAR’s operational strategy with a key focus on ensuring quality deliverables and providing a positive customer experience.

Alzheimer’s Disease Diagnostic Market – Global Industry Size, Trends and COVID-19 Impact Analysis (2022 to 2028)

Sharp Adds New Talent in Global Operations and Finance to Senior Leadership Team

Citeline and Norstella Unite to Offer Life Sciences Clients a Full Suite of Commercial and Clinical Solutions

Citeline and Norstella Unite to create a new organization that will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to patient

BOC Sciences Demonstrates Comprehensive Strength with LYTAC Technology

BOC Sciences demonstrates its comprehensive strength with innovative LYTAC degradation technology solutions developed in the field of targeted protein degradation.

One-stop Mitochondria-focused Testing Services Targeting to Preclinical Studies of Cardiac Diseases

Creative Biogene offers one-stop mitochondria-focused testing services for the evaluation of a variety of cardiac diseases associated with mitochondrial dysfunction.

MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth

MMS Holdings, a contract research organization, announced today that Lindsay Goldberg, a private equity firm, has completed an investment in the company. The partnership will help MMS expand its data-focused clinical research services.

Creative Proteomics Cytokine Boosts Your Research and Discovery with Mouse Cytokine Assay